Atlas Venture Fund XI, L.P. is 10% at Day One Biopharmaceuticals, Inc. (DAWN). They have made 1 open-market trade across 1 company since 2024, most recently 2025-02-10.
CIK 0001708269
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLO | SELL | 2024-02-08 | 2024-02-09 | $0.64 | $640 | -19.1% | +11.3% | +85.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.